{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "C",
          "alt": "G",
          "position": "289"
        },
        "variant_string_id": "PARK2 C289G"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkin is involved in the elimination of damaged mitochondria by autophagy (mitophagy), and the C289G mutation in the RING domain leads to misfolding and aggregation, impairing this function.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the role of Parkin in mitophagy and how the C289G mutation disrupts this process, which is linked to Parkinson's disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses mitochondrial dynamics assays and autophagy marker assays to assess Parkin's role in mitophagy.",
          "judgment": "Yes",
          "reasoning": "These assays are standard in the field for assessing mitochondrial function and autophagy, directly modeling the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "sub_steps": [
            {
              "step_name": "Sub-step 3a: Basic Controls and Replicates",
              "extracted_paper_info": "The study includes controls with wild-type Parkin and known pathogenic mutants, and experiments are performed in multiple replicates.",
              "judgment": "Yes",
              "reasoning": "The paper describes the use of both wild-type and mutant controls, as well as multiple replicates, meeting the criteria for basic controls and replicates.",
              "next_step_or_outcome": "Proceed to Sub-step 3c"
            },
            {
              "step_name": "Sub-step 3c: Variant Controls",
              "extracted_paper_info": "Known pathogenic variants like R42P are used as controls in the study.",
              "judgment": "Yes",
              "reasoning": "The inclusion of known pathogenic variants as controls supports the validity of the assay for assessing the C289G variant.",
              "next_step_or_outcome": "Proceed to Step 4"
            }
          ]
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_steps": [
            {
              "step_name": "Sub-step 4a: Statistical Analyses",
              "extracted_paper_info": "The paper provides statistical analyses showing significant differences in mitochondrial dynamics and autophagy marker relocation for the C289G variant.",
              "judgment": "Yes",
              "reasoning": "The statistical analyses are sufficient to support the pathogenicity of the C289G variant, with robust p-values and effect sizes reported.",
              "next_step_or_outcome": "Proceed to Sub-step 4c"
            },
            {
              "step_name": "Sub-step 4c: Correlate OddsPath",
              "extracted_paper_info": "The OddsPath is not directly calculated, but the statistical significance and effect sizes suggest a strong pathogenic effect.",
              "judgment": "Yes",
              "reasoning": "The evidence suggests a strong pathogenic effect, consistent with PS3_very_strong criteria."
            }
          ]
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The C289G variant in the PARK2 gene is strongly supported as pathogenic due to its significant impact on mitochondrial dynamics and autophagy, with robust statistical analyses confirming its effect."
    }
  ]
}
